INSL4 Polyclonal Antibody

INSL4 encodes the Early placenta insulin-like peptide, a member of the insulin superfamily. INSL4 encodes a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. Expression of INSL4 products occurs within the early placental cytotrophoblast and syncytiotrophoblast.

The INSL4 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of insulin-like peptide 4 (INSL4) in various biological samples. This antibody is produced using state-of-the-art techniques, ensuring high affinity and specificity towards INSL4.

INSL4 is a member of the insulin-like peptide family and has been implicated in various physiological processes, including reproductive function and cancer development. The INSL4 Polyclonal Antibody offers researchers a reliable and accurate means to study the role of INSL4 in these processes.

This antibody has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA). It exhibits excellent sensitivity and specificity, enabling the detection of low levels of INSL4 in complex biological samples.

The INSL4 Polyclonal Antibody is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation. It is provided in a convenient size, ensuring cost-effectiveness and minimizing wastage.

With its exceptional performance and ease of use, the INSL4 Polyclonal Antibody is an indispensable tool for researchers studying the role of INSL4 in various biological processes. Its high specificity and sensitivity make it an ideal choice for accurate and reliable detection and quantification of INSL4 in diverse sample types.